Randomized Phase III Study of Amcenestrant Plus Palbociclib Versus Letrozole Plus Palbociclib in Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: ...
Bosutinib treatment was associated with a 66% decrease in the annual rate of kidney enlargement. In a phase 2 study, bosutinib, an oral drug approved for treating certain cases of chronic myeloid ...
Immunotherapy with immune checkpoint inhibitors is standard first-line treatment for advanced renal cell carcinoma (RCC), but not every patient responds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback